Adial Pharmaceuticals Inc. | Press Release

archive,category,category-press-release,category-96,ajax_fade,page_not_loaded,,qode-theme-ver-16.2.1,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.7,vc_responsive

Press Release

Posted at 09 May, 17:34h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder

Posted at 29 Apr, 19:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceutical’s Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate

Posted at 26 Mar, 13:22h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer

Posted at 28 Feb, 15:13h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Featured on CBS in San Francisco

Posted at 20 Feb, 14:08h in Press Release by adialpharma 0 Comments

0 Likes

ADIAL PHARMACEUTICALS ANNOUNCES PARTNERSHIP WITH CATALENT TO PACKAGE AND DISTRIBUTE ADIAL’S AD04 FOR ITS PHASE 3 TRIAL

Posted at 12 Feb, 14:39h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

Posted at 07 Feb, 14:31h in Press Release by adialpharma 0 Comments

0 Likes

DR. BANKOLE A. JOHNSON, CHAIRMAN OF ADIAL PHARMACEUTICALS, RECEIVES PRESTIGIOUS AMERICAN SOCIETY OF ADDICTION MEDICINE AWARD

Posted at 01 Feb, 14:25h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder

Posted at 30 Jan, 14:25h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants

Posted at 18 Jan, 15:09h in Press Release by adialpharma 0 Comments

0 Likes

Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder